GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon

Mohamed Alsharif, Omran Shrebaty, Mohammad Ammar Aloudah, Mayar Alqahtani, Raghad Saud Aloubili, Marafi Jammaa Ahmed, Bana Albani, Ahmad El Bana

Open source

DOI: 10.3389/fnagi.2026.1969490
Published: 2026-10-07
Container: Frontiers in Aging Neuroscience
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fnagi.2026.1969490,
  title = {GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon},
  author = {Mohamed Alsharif and Omran Shrebaty and Mohammad Ammar Aloudah and Mayar Alqahtani and Raghad Saud Aloubili and Marafi Jammaa Ahmed and Bana Albani and Ahmad El Bana},
  year = {2026},
  journal = {Frontiers in Aging Neuroscience},
  doi = {10.3389/fnagi.2026.1969490},
  url = {https://doi.org/10.3389/fnagi.2026.1969490}
}

RIS

TY  - JOUR
TI  - GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon
AU  - Mohamed Alsharif
AU  - Omran Shrebaty
AU  - Mohammad Ammar Aloudah
AU  - Mayar Alqahtani
AU  - Raghad Saud Aloubili
AU  - Marafi Jammaa Ahmed
AU  - Bana Albani
AU  - Ahmad El Bana
PY  - 2026
JO  - Frontiers in Aging Neuroscience
DO  - 10.3389/fnagi.2026.1969490
UR  - https://doi.org/10.3389/fnagi.2026.1969490
ER  -

APA

Alsharif, M., Shrebaty, O., Aloudah, M. A., Alqahtani, M., Aloubili, R. S., Ahmed, M. J., Albani, B., & Bana, A. E. (2026). GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2026.1969490

Source records

crossref · retrieved 2026-11-08T21:10:12.080Z